Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

PURPOSE: Pathologic response assessment of tumor specimens from patients receiving systemic treatment provide an early indication of therapeutic efficacy and predict long-term survival. Grading systems for pathologic response were first developed for chemotherapy in select tumor types. Immunotherape...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Autores principales: Stein, Julie E., Lipson, Evan J., Cottrell, Tricia R., Forde, Patrick M., Anders, Robert A., Cimino-Mathews, Ashley, Thompson, Elizabeth D., Allaf, Mohamad E., Yarchoan, Mark, Feliciano, Josephine, Wang, Hao, Jaffee, Elizabeth M., Pardoll, Drew M., Topalian, Suzanne L., Taube, Janis M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7002263/
https://ncbi.nlm.nih.gov/pubmed/31672770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2379
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares